Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PTAFR | P25105 | 2/20 | 0.46 |
| ▸ | ICMT | O60725 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14492285 | 0.89 | CYP19A1 (0.51) | CNR1CNR2PPARATDP1L3MBTL1 | |
| SCHEMBL14680905 | 0.83 | CYP3A4 (0.41) | TDP1L3MBTL1CYP3A4CYP2D6PTAFR | |
| SCHEMBL21480390 | 0.81 | PPARA (0.55) | CNR1CNR2PPARATDP1L3MBTL1 | |
| SCHEMBL4585984 | 0.79 | PPARA (0.47) | CNR1CNR2PPARATDP1L3MBTL1 | |
| Methyl Alcohol SCHEMBL27900235 | 0.79 | TYR (0.46) | PPARATDP1CYP3A4 | |
| Water SCHEMBL28833009 | 0.77 | TYR (0.43) | PPARATDP1CYP3A4TLR8 | |
| SCHEMBL19826512 | 0.76 | CYP11B1 (0.47) | CYP3A4CYP2D6CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL14680982 | 0.76 | CYP1A2 (0.47) | CYP2D6CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL10429729 | 0.75 | LIPG (0.45) | PPARA | |
| SCHEMBL13527201 | 0.74 | TDP1 (0.65) | PPARATDP1L3MBTL1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796461-B2 | 1,2,4,5-substituted phenyl compound, method for producing same and organic electroluminescent device comprising same as constituent | TOSOH CORPORATION (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20130035491-A1 | 1,2,4, 5-SUBSTITUTED PHENYL COMPOUND, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT | TOSOH CORPORATION (JP) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035491-A1 | 1,2,4, 5-SUBSTITUTED PHENYL COMPOUND, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT | XDH, OR10J3, HAX1 | CNR1 827/4885CNR2 889/4885PPARA 3933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.